Title : Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.

Pub. Date : 2009 Nov 15

PMID : 19530244






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 On comparing the efficacy of gefitinib with that of docetaxel, it was found that the median progression-free survival was significantly longer for patients treated with gefitinib than those with docetaxel in those harboring plasma EGFR mutation (7.609 vs. 3.192 months, p = 0.006). Docetaxel epidermal growth factor receptor Homo sapiens
2 On comparing the efficacy of gefitinib with that of docetaxel, it was found that the median progression-free survival was significantly longer for patients treated with gefitinib than those with docetaxel in those harboring plasma EGFR mutation (7.609 vs. 3.192 months, p = 0.006). Docetaxel epidermal growth factor receptor Homo sapiens